CN108785559A - 一种治疗呼吸道感染的药物及其制备方法 - Google Patents
一种治疗呼吸道感染的药物及其制备方法 Download PDFInfo
- Publication number
- CN108785559A CN108785559A CN201811082615.8A CN201811082615A CN108785559A CN 108785559 A CN108785559 A CN 108785559A CN 201811082615 A CN201811082615 A CN 201811082615A CN 108785559 A CN108785559 A CN 108785559A
- Authority
- CN
- China
- Prior art keywords
- parts
- respiratory tract
- tract infection
- medicine
- mulberry leaves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 206010057190 Respiratory tract infections Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 229940079593 drug Drugs 0.000 title description 17
- 240000008467 Oryza sativa Japonica Group Species 0.000 claims abstract description 27
- 240000000249 Morus alba Species 0.000 claims abstract description 26
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 26
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 24
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 23
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 23
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 23
- 229940010454 licorice Drugs 0.000 claims abstract description 23
- 239000011435 rock Substances 0.000 claims abstract description 23
- 241000605372 Fritillaria Species 0.000 claims abstract description 22
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 21
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 21
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241000202807 Glycyrrhiza Species 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 21
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 20
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000007796 conventional method Methods 0.000 claims description 3
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 claims description 2
- 240000002495 Cucumis melo var. inodorus Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 241000251468 Actinopterygii Species 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 241000700605 Viruses Species 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 28
- 206010011224 Cough Diseases 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000000144 pharmacologic effect Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 11
- 206010037660 Pyrexia Diseases 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 208000027744 congestion Diseases 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010062106 Respiratory tract infection viral Diseases 0.000 description 4
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000002155 anti-virotic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 229960000329 ribavirin Drugs 0.000 description 3
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 208000020017 viral respiratory tract infection Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000007791 dehumidification Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- IXUYISWDRMQAKU-UHFFFAOYSA-N 2-morpholin-4-ylguanidine Chemical compound NC(=N)NN1CCOCC1 IXUYISWDRMQAKU-UHFFFAOYSA-N 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- -1 Fritillaria Natural products 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010045168 Tumour embolism Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 201000005180 acute myocarditis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- QLNRDLPNCSSERI-UHFFFAOYSA-N guanidine;morpholine Chemical compound NC(N)=N.C1COCCN1 QLNRDLPNCSSERI-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000005985 stomach dysfunction Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗呼吸道感染的药物,其原料由以下重量份数的组分组成:桑叶3~5份、地骨皮3~5份、浙贝母3~5份、鱼腥草3~5份、金银花3~5份、黄芩3~5份、大枣1~3份、粳米1~2份、冰糖1~2份、炙甘草1~2份。此外,本发明还提供了一种治疗呼吸道感染的药物的制备方法。本发明提供的治疗呼吸道感染的药物对治疗各种病毒引起的呼吸道感染具有显著的疗效,安全可靠,无毒副作用,能够达到标本兼治的目的,值得广泛推广应用。
Description
技术领域
本发明涉及中药技术领域,具体公开一种治疗呼吸道感染的药物及其制备方法。
背景技术
呼吸道感染分为上呼吸道感染与下呼吸道感染。上呼吸道感染是指自鼻腔至喉部之间的急性炎症的总称,是最常见的感染性疾病。上呼吸道感染90%左右由病毒引起,细菌感染常继发于病毒感染之后。常继发支气管炎、肺炎、副鼻窦炎,少数人可并发急性心肌炎、肾炎、风湿热等。下呼吸道感染是最常见的感染性疾患。无论是下呼吸道感染还是上呼吸道感染,绝大部分是由病毒引起的,称为:病毒性呼吸道感染。
西医常用的抗病毒西药有利巴韦林、吗啉胍等,但利巴韦林可引起溶血性贫血、导致白细胞减少,还可引起皮疹、腹泻、胃肠道出血以及血清胆红素升高;吗啉胍有胃肠道反应如恶心、呕吐、食欲减退,也有过敏性皮疹皮痒的表现,个别可引起出汗、低血糖等反应。而中药抗病毒具有较多的优势,一是在抗病毒同时,许多药物兼有解热、抗炎等作用,对病毒引起的感染具有多重作用,如缩短发热的时间、控制炎症的扩散、促进炎症的吸收等,即多途径、多方位起作用;二是在抗病毒同时,部分药物还能增强机体免疫功能,阻止病毒进入细胞组织;三是在抗病毒同时,一般很少伤害正常组织细胞,毒副作用较小。正是由于这种治疗过程中中药有效成分的多元化,病毒难以对其产生抗药性,使得中药在治疗病毒感染性疾病方面具有明显的优势,临床使用前景广阔。
发明内容
本发明提供一种治疗呼吸道感染的药物,所选药材配伍相宜,对治疗各种病毒引起的呼吸道感染具有显著的疗效,安全可靠,能够达到标本兼治的目的,值得广泛推广应用。
本发明的第一个目的是提供一种治疗呼吸道感染的药物,其原料由以下重量份数的组分组成:桑叶3~5份、地骨皮3~5份、浙贝母3~5份、鱼腥草3~5份、金银花3~5份、黄芩3~5份、大枣1~3份、粳米1~2份、冰糖1~2份、炙甘草1~2份。
优选地,其原料具体由以下重量份数的组分组成:桑叶4份、地骨皮4份、浙贝母4份、鱼腥草4份、金银花4份、黄芩4份、大枣2份、粳米2份、冰糖1份、炙甘草1份。
优选地,所述桑叶为蜜制桑叶。
本发明的第二个目的是提供一种治疗呼吸道感染的药物的制备方法,具体按照以下步骤实施:
步骤1,按重量份数称取桑叶3~5份、地骨皮3~5份、浙贝母3~5份、鱼腥草3~5份、金银花3~5份、黄芩3~5份、大枣1~3份、粳米1~2份、冰糖1~2份、炙甘草1~2份,备用;
步骤2,将步骤1中称取的桑叶、地骨皮、浙贝母、鱼腥草、金银花、黄芩、大枣、粳米、冰糖、炙甘草混合,加入相当于其总重量8~12倍的水,文火煎煮1.5~2.5h,煎煮完毕后过滤,得第一次滤液;滤渣加入相当于其总重量6~10倍的水,继续使用文火煎煮1.0~2.0h,煎煮完毕后过滤,得第二次滤液,合并第一次滤液及第二次滤液,浓缩成相当于原生药材1g/mL的浓缩液,所述浓缩液即为所述药物,将浓缩液于4℃冷藏备用。
优选地,所述药物能够按照常规方法制成药学上可接受的中药制剂。
优选地,所述中药制剂的药用剂型为汤剂、颗粒剂、胶囊剂、口服液或片剂。
本发明各组分的功效及药理作用:
1、桑叶:味苦,甘,性寒。归肺、肝经。清肝养肝、疏散风热、清肺、明目。主治风热感冒,风温初起,发热头痛,汗出恶风,咳嗽胸痛;或肺燥干咳无痰;咽干口渴;风热及肝阳上扰;目赤肿痛。现代药理研究证明,桑叶具有抗凝血、降血压、降血糖、降血脂、降胆固醇、抗血栓形成和抗动脉粥样硬化作用;还可以抗衰老、抗疲劳、抗丝虫病,还有抑菌、抗炎、抗肿瘤的作用;另外,桑叶能够改善肠功能、润肠通便及减肥。
2、地骨皮:性寒,味甘。入肺、肝、肾经。凉血除蒸,清肺降火。用于阴虚潮热、骨蒸盗汗、肺热咳嗽、咯血、衄血,内热消渴。现代药理研究证明,地骨皮具有降压、降血糖及降血脂的作用;还可以解热,抗病原微生物。
3、浙贝母:味苦,性寒,入心、肺经。清热化痰,散结解毒。治风热咳嗽,肺痈喉痹,瘰疬,疮疡肿毒。现代药理研究证实,浙贝母含有浙贝母碱等多种生物碱,浙贝母碱具有缓解支气管平滑肌痉挛、减少支气管黏膜分泌、扩大瞳孔、降低血压、兴奋子宫等多种药理作用。
4、鱼腥草:味辛、性寒凉。清热解毒、排痛消肿疗疮、利尿除湿、健胃消食。主治实热、热毒、湿邪、疾热为患的肺痈、疮疡肿毒、痔疮便血、脾胃积热等。现代药理研究证明,鱼腥草能够消炎、抗菌、抗病毒,并且提高人体免疫力;还具有利尿作用。
5、金银花:性寒,味甘。入肺、心、胃经。清热解毒、抗炎、补虚疗风。主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。现代药理研究证明,金银花能够降血脂,抗内毒素,加强机体免疫功能,抗炎、解热,抗病原微生物,对中枢亦有兴奋作用。
6、黄芩:性寒,味苦。入心、肺、胆、大肠经。泻实火,除湿热,止血,安胎。主治壮热烦渴,肺热咳嗽,湿热泻痢,黄疸,热淋,吐、衄、崩、漏,目赤肿痛,胎动不安,痈肿疔疮。现代药理研究证明,黄芩能够抗菌、抗炎、抗病毒,抗血小板凝集,降血脂,保肝利胆、抗氧化,抗癌,对中枢神经及心血管系统亦有一定的作用。
7、大枣:甘,温。归脾、胃经。补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。现代药理研究证明,大枣有保肝护肝、防止脱发、健胃补脑、促进睡眠的作用,还可以美容养颜,减少老人斑。
8、粳米:味甘,性平。益脾胃,除烦渴。用于呕吐、泻痢或温热病所致的脾胃阴伤、胃气不足,口干渴等。现代药理研究证明,粳米米糠层的粗纤维分子,有助胃肠蠕动,对胃病、便秘、痔疮等疗效很好;粳米能提高人体免疫功能,促进血液循环,从而减少高血压的机会;粳米能预防糖尿病、脚气病、老年斑和便秘等疾病;粳米中的蛋白质、脂肪、维生素含量都比较多,多吃能降低胆固醇,减少心脏病发作和中风的几率;粳米可防过敏性疾病。
9、冰糖:味甘、性平、无毒。入肺、脾经。养阴生津,润肺止咳。主治:肺燥咳嗽,干咳无痰,咯痰带血。用于肺燥、肺虚、风寒劳累所致的咳喘、小儿疟疾、噤口痢、口疮、风火牙痛。现代药理研究证明,冰糖能补充体内水分和糖分,具有补充体液、供给能量、补充血糖、强心利尿、解毒等作用。
10、炙甘草:性平,味甘,归十二经。补脾益气,滋咳润肺,缓急解毒,调和百药。生用主治咽喉肿痛,痛疽疮疡,胃肠道溃疡以及解药毒、食物中毒等;蜜炙主治脾胃功能减退,大便溏薄,乏力发热以及咳嗽、心悸等。现代药理研究表明,炙甘草有类似肾上腺皮质激素样作用,对组胺引起的胃酸分泌过多有抑制作用;并有抗酸和缓解胃肠平滑肌痉挛作用;炙甘草还有抗炎,抗过敏作用,能保护发炎的咽喉和气管粘膜;炙甘草含有炙甘草素,有助于平衡女性体内的激素含量;炙甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。
中医临床研究结果证明,呼吸道感染形成病因多以风热犯肺、痰热壅肺为主,另有气阴两虚、热陷心包、阴竭阳脱亦可导致呼吸道感染。
本方以桑叶、地骨皮、浙贝母为君药,疏散风热、清肺润燥、化痰;鱼腥草、金银花、黄芩为臣药,鱼腥草、金银花助君药疏散风热、解毒之效,黄芩入心、肺经,泻实火、清湿热,解湿热犯肺、热陷心包之症;大枣、粳米、冰糖为佐药,大枣补中益气,健脾安神,滋补脾气,助脾运化水湿,解水湿停滞于肺而痰湿壅肺之症,粳米益脾胃,助大枣补益脾气,缓解湿热内停导致的脾胃阴伤,冰糖养阴生津,润肺止咳,助全方养阴润肺之效;炙甘草为使药,补脾益气,滋咳润肺,缓急解毒,调和百药。全方诸药合用,润肺化痰、宣肺止咳、补气和中、养阴生津,对于痰热壅肺、气阴两虚、热陷心包导致的呼吸道感染疗效显著。
对比现有技术,本发明的有益效果为:
1、本发明提供的治疗呼吸道感染的药物,所选药材配伍相宜,符合传统中医理论和现代医药学理论,具有润肺化痰、宣肺止咳、补气和中、养阴生津之功效。
2、本发明提供的治疗呼吸道感染的药物对治疗各种病毒引起的呼吸道感染具有显著的疗效,安全可靠,无毒副作用,能够达到标本兼治的目的。
具体实施方式
为了使本领域技术人员更好地理解本发明的技术方案能予以实施,下面结合具体实施例对本发明作进一步说明,但所举实施例不作为对本发明的限定。
本发明各实施例中所用桑叶、地骨皮、浙贝母、鱼腥草、金银花、黄芩、大枣、粳米、冰糖、炙甘草均为市售,所述试验方法,如无特殊说明,均为常规方法。
实施例1
一种治疗呼吸道感染的药物,其原料由以下重量份数的组分组成:蜜制桑叶3份、地骨皮3、浙贝母3、鱼腥草3、金银花3、黄芩3、大枣1、粳米1、冰糖1份、炙甘草1份。
具体按照以下步骤实施:
步骤1,按重量份数称取蜜制桑叶3份、地骨皮3、浙贝母3、鱼腥草3、金银花3、黄芩3、大枣1、粳米1、冰糖1份、炙甘草1份,备用;
步骤2,将步骤1中称取的蜜制桑叶、地骨皮、浙贝母、鱼腥草、金银花、黄芩、大枣、粳米、冰糖、炙甘草混合,加入相当于其总重量8倍的水,文火煎煮1.5h,煎煮完毕后过滤,得第一次滤液;滤渣加入相当于其总重量6倍的水,继续使用文火煎煮1.0h,煎煮完毕后过滤,得第二次滤液,合并第一次滤液及第二次滤液,浓缩成相当于原生药材1g/mL的浓缩液,所述浓缩液即为所述药物,将浓缩液于4℃冷藏备用。
所得浓缩液即为汤剂剂型的治疗呼吸道感染的药物。
实施例2
一种治疗呼吸道感染的药物,其原料由以下重量份数的组分组成:蜜制桑叶5份、地骨皮5份、浙贝母5份、鱼腥草5份、金银花5份、黄芩5份、大枣3份、粳米2份、冰糖2份、炙甘草2份。
具体按照以下步骤实施:
步骤1,按重量份数称取蜜制桑叶5份、地骨皮5份、浙贝母5份、鱼腥草5份、金银花5份、黄芩5份、大枣3份、粳米2份、冰糖2份、炙甘草2份,备用;
步骤2,将步骤1中称取的蜜制桑叶、地骨皮、浙贝母、鱼腥草、金银花、黄芩、大枣、粳米、冰糖、炙甘草混合,加入相当于其总重量12倍的水,文火煎煮2.5h,煎煮完毕后过滤,得第一次滤液;滤渣加入相当于其总重量10倍的水,继续使用文火煎煮2.0h,煎煮完毕后过滤,得第二次滤液,合并第一次滤液及第二次滤液,浓缩成相当于原生药材1g/mL的浓缩液,所述浓缩液即为所述药物,将浓缩液于4℃冷藏备用。
将所得浓缩液加入适量辅料,混匀、制粒,过筛,干燥,即得颗粒剂型的治疗呼吸道感染的药物。
实施例3
一种治疗呼吸道感染的药物,其原料由以下重量份数的组分组成:蜜制桑叶4份、地骨皮4份、浙贝母4份、鱼腥草4份、金银花4份、黄芩4份、大枣2份、粳米2份、冰糖1份、炙甘草1份。
具体按照以下步骤实施:
步骤1,按重量份数称取蜜制桑叶4份、地骨皮4份、浙贝母4份、鱼腥草4份、金银花4份、黄芩4份、大枣2份、粳米2份、冰糖1份、炙甘草1份,备用;
步骤2,将步骤1中称取的蜜制桑叶、地骨皮、浙贝母、鱼腥草、金银花、黄芩、大枣、粳米、冰糖、炙甘草混合,加入相当于其总重量10倍的水,文火煎煮2.0h,煎煮完毕后过滤,得第一次滤液;滤渣加入相当于其总重量8倍的水,继续使用文火煎煮1.5h,煎煮完毕后过滤,得第二次滤液,合并第一次滤液及第二次滤液,浓缩成相当于原生药材1g/mL的浓缩液,所述浓缩液即为所述药物,将浓缩液于4℃冷藏备用。
将所得浓缩液加入适量辅料,混匀、制粒,过筛,干燥,再将制得的颗粒物经进一步压片,干燥,即得片剂型的治疗呼吸道感染的药物。
实施例1~3均制备出了效果良好的治疗呼吸道感染的药物,由于实施例1~3制备出的用于治疗呼吸道感染的药物效果基本平行,因此仅采用实施例1制备出的药物来对本发明的效果进行说明。
1资料与方法
1.1一般资料
该次研究纳入对象为120例呼吸道感染患者。随机将120例患者分为对照组1、对照组2和治疗组,每组40例。
对照组1中有男性22例,女性18例,年龄在20~63岁之间,平均年龄为(42.6±1.8)岁;
对照组2中有男性19例,女性21例,年龄在22~65岁之间,平均年龄为(41.8±1.5)岁;
治疗组中有男性21例,女性19例,年龄在21~60岁之间,平均年龄为(41.2±2.3)岁。
120例患者均符合病毒性呼吸道感染诊断标准,该次研究已获得患者同意。排除药物过敏、其他疾病、妊娠期、哺乳期等患者。三组患者基础资料对比差异无统计学意义(P>0.05),有可比性。
1.2诊断标准
西医诊断标准参照《中药新药临床研究指导原则》拟定:(1)鼻塞流涕、打喷嚏,鼻粘膜充血、水肿,可有咳嗽咳痰、声音嘶哑、咽喉疼痛不适、咽喉部充血等;(2)可有发热寒战、头疼头昏、全身不适、四肢等酸痛等;(3)血常规检查提示白细胞正常或偏低,淋巴细胞可升高。
中医证候诊断:风热证:(1)主症:身热较著,微恶风,汗泄不畅,咽燥,或咽喉乳蛾肿痛,鼻塞,流浊涕,脉浮数;(2)次症:头胀痛,咳嗽,痰黏或黄,口渴欲饮,舌苔薄白微黄,边尖红。
1.3纳入标准
符合病毒性呼吸道感染西医、中医证候诊断标准,男女不限,年龄40~80岁,呼吸道感染病程<48h,患者或其家属签署知情同意书,就诊前未使用抗感染药物治疗。
1.4治疗方法
对照组1:清热解毒颗粒(国药准字Z20053600),口服,一日3次,一次1~2袋,疗程5d;
对照组2:利巴韦林颗粒(国药准字H20044779),口服,一次0.15g,一日3次,治疗7d为1个疗程;
治疗组:实施例1制备的药物口服,1剂/d,2~3次/d,疗程5d。
1.5观察指标
观察治疗期间患者发热、咳嗽、鼻腔黏膜充血、水肿、有分泌物,咽部轻度充血等变化情况。
1.6疗效判定标准
临床痊愈:治疗48h后体温恢复正常,治疗3d后患者呼吸道感染症状消失;
显效:48h后体温恢复正常,治疗3d后患者呼吸道症状疾病消失,可有轻微咳嗽、咽喉部不适等;
有效:治疗3d后体温恢复正常,有可有轻微咳嗽咳痰不适,鼻粘膜轻微充血,咽喉部轻微红肿;
无效:患者仍有发热不适,呼吸道感染症状未见明显缓解。
总有效率=(痊愈+显效+有效)/总例数×100%。
1.7统计学方法
采用SPSS16.0统计学软件处理数据。计量资料以均数±标准差表示,采用t检验;计数资料以率(%)表示,采用χ2检验。P<0.05表示差异具有统计学意义。
2治疗效果
治疗一个疗程后,治疗组临床有效率为97.5%,高于对照组1的92.5%,高于对照组2的65.0%,且治疗组与对照组2之间比较差异具有统计学意义(P<0.05)。结果见表1。
表1对照组与治疗组临床治疗效果比较
组别 | 痊愈 | 显效 | 有效 | 无效 | 总有效率(%) |
对照组1 | 27 | 6 | 4 | 3 | 92.5 |
对照组2 | 21 | 3 | 2 | 14 | 65.0 |
治疗组 | 30 | 5 | 4 | 1 | 97.5* |
*:P<0.05VS对照组2。
通过临床观察发现,治疗1个疗程后后,治疗组临床总有效率为97.5%,高于对照组1的92.5%,高于对照组2的65.0%,且治疗组与对照组2之间比较差异具有统计学意义(P<0.05)。说明实施例1制备的药物治疗病毒性呼吸道感染疗效确切,效果显著。
需要说明的是,本发明权利要求书中涉及数值范围时,应理解为每个数值范围的两个端点以及两个端点之间任何一个数值均可选用,由于采用的步骤方法与实施例1~3相同,为了防止赘述,本发明描述了优选的实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例作出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。
Claims (6)
1.一种治疗呼吸道感染的药物,其特征在于,其原料由以下重量份数的组分组成:桑叶3~5份、地骨皮3~5份、浙贝母3~5份、鱼腥草3~5份、金银花3~5份、黄芩3~5份、大枣1~3份、粳米1~2份、冰糖1~2份、炙甘草1~2份。
2.根据权利要求1所述的治疗呼吸道感染的药物,其特征在于,其原料具体由以下重量份数的组分组成:桑叶4份、地骨皮4份、浙贝母4份、鱼腥草4份、金银花4份、黄芩4份、大枣2份、粳米2份、冰糖1份、炙甘草1份。
3.根据权利要求1或2所述的治疗呼吸道感染的药物,其特征在于,所述桑叶为蜜制桑叶。
4.根据权利要求1所述的治疗呼吸道感染的药物的制备方法,其特征在于,具体按照以下步骤实施:
步骤1,按重量份数称取桑叶3~5份、地骨皮3~5份、浙贝母3~5份、鱼腥草3~5份、金银花3~5份、黄芩3~5份、大枣1~3份、粳米1~2份、冰糖1~2份、炙甘草1~2份,备用;
步骤2,将步骤1中称取的桑叶、地骨皮、浙贝母、鱼腥草、金银花、黄芩、大枣、粳米、冰糖、炙甘草混合,加入相当于其总重量8~12倍的水,文火煎煮1.5~2.5h,煎煮完毕后过滤,得第一次滤液;滤渣加入相当于其总重量6~10倍的水,继续使用文火煎煮1.0~2.0h,煎煮完毕后过滤,得第二次滤液,合并第一次滤液及第二次滤液,浓缩成相当于原生药材浓度为1g/mL的浓缩液,所述浓缩液即为所述治疗呼吸道感染的药物,将浓缩液于4℃冷藏备用。
5.根据权利要求4所述的治疗呼吸道感染的药物的制备方法,其特征在于,所述药物能够按照常规方法制成药学上可接受的中药制剂。
6.根据权利要求5所述的治疗呼吸道感染的药物的制备方法,其特征在于,所述中药制剂的药用剂型为汤剂、颗粒剂、胶囊剂、口服液或片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811082615.8A CN108785559B (zh) | 2018-09-17 | 2018-09-17 | 一种治疗呼吸道感染的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811082615.8A CN108785559B (zh) | 2018-09-17 | 2018-09-17 | 一种治疗呼吸道感染的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108785559A true CN108785559A (zh) | 2018-11-13 |
CN108785559B CN108785559B (zh) | 2021-07-02 |
Family
ID=64082071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811082615.8A Active CN108785559B (zh) | 2018-09-17 | 2018-09-17 | 一种治疗呼吸道感染的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108785559B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110025722A (zh) * | 2019-05-22 | 2019-07-19 | 湖南众一医药咨询有限公司 | 治疗呼吸道感染的中药组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480191A (zh) * | 2003-07-09 | 2004-03-10 | 石世德 | 一种预防和治疗肺炎、支气管炎、咽炎及上呼吸道感染的药物及其制备方法 |
CN1876099A (zh) * | 2005-06-10 | 2006-12-13 | 房凯 | 银贝止咳颗粒 |
CN101919961A (zh) * | 2009-06-10 | 2010-12-22 | 青岛国风药业股份有限公司 | 一种治疗感冒的药物组合物及其制备方法 |
CN102119967A (zh) * | 2010-12-21 | 2011-07-13 | 肖泽林 | 一种预防呼吸道传染病的药物 |
-
2018
- 2018-09-17 CN CN201811082615.8A patent/CN108785559B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480191A (zh) * | 2003-07-09 | 2004-03-10 | 石世德 | 一种预防和治疗肺炎、支气管炎、咽炎及上呼吸道感染的药物及其制备方法 |
CN1876099A (zh) * | 2005-06-10 | 2006-12-13 | 房凯 | 银贝止咳颗粒 |
CN101919961A (zh) * | 2009-06-10 | 2010-12-22 | 青岛国风药业股份有限公司 | 一种治疗感冒的药物组合物及其制备方法 |
CN102119967A (zh) * | 2010-12-21 | 2011-07-13 | 肖泽林 | 一种预防呼吸道传染病的药物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110025722A (zh) * | 2019-05-22 | 2019-07-19 | 湖南众一医药咨询有限公司 | 治疗呼吸道感染的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108785559B (zh) | 2021-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102416095A (zh) | 一种治疗扁桃体炎、咽炎的中药组合物 | |
CN103041030B (zh) | 一种治疗大头瘟的药物组合物及其制备方法和用途 | |
CN103028060B (zh) | 用于治疗婴幼儿急性湿疹的中药组合物及其制备方法 | |
CN108785559A (zh) | 一种治疗呼吸道感染的药物及其制备方法 | |
CN104189605B (zh) | 一种用于治疗急性鼻咽炎的中药制剂及制备方法 | |
CN104383318A (zh) | 一种治疗肺结核的中药组合物及其制备方法 | |
CN104524174A (zh) | 一种治疗风湿痹痛的中药组合物及其制备方法 | |
CN104998162A (zh) | 一种治疗咳嗽的药物及其制备方法 | |
CN100455319C (zh) | 一种治疗小儿咳嗽中药制剂及制备方法 | |
CN100389802C (zh) | 治疗和预防慢性阻塞性肺病的药 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN103055218A (zh) | 用于治疗新生儿黄疸的中药组合物及其制备方法 | |
CN106620205A (zh) | 一种治疗小儿发烧泡脚外用的中药 | |
CN105434739A (zh) | 一种治疗霰粒肿的中药组合物及其制备方法 | |
CN105194165B (zh) | 一种用于泌尿系统感染的中药及制备方法 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN104587034B (zh) | 一种药物组合物在用于制备治疗口腔溃疡的新用途 | |
CN113304218B (zh) | 治疗猫杯状病毒感染的中药 | |
CN108186864A (zh) | 一种治疗痤疮的中药 | |
CN104784567B (zh) | 一种治疗泌尿系感染的药物组合物 | |
CN104587035A (zh) | 一种治疗口腔溃疡的药物组合物及其制备方法 | |
CN104435674B (zh) | 一种治疗小儿低热的中药组合物及其制备方法 | |
CN105311602A (zh) | 一种防治小儿哮喘的中药组合物 | |
CN112022936A (zh) | 一种扁桃体保健贴及其制备方法 | |
CN119733022A (zh) | 一种用于治疗慢性肠炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |